{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:21Z","timestamp":1791923061476,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073540"],"award-info":[{"award-number":["82073540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clnu.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:46:07Z","timestamp":1715949967000},"page":"1599-1608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A panel of four plasma amino acids is a promising biomarker for newly diagnosed bladder cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Zhipeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-6365","authenticated-orcid":false,"given":"Yujuan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.05.003_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1170124","article-title":"Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs","volume":"13","author":"Grabe-Heyne","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.clnu.2024.05.003_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clnu.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40273-023-01256-9","article-title":"Critical appraisal of decision models used for the economic evaluation of bladder cancer screening and diagnosis: a systematic review","volume":"41","author":"Mandrik","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.clnu.2024.05.003_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188926","article-title":"Off the fog to find the optimal choice: research advances in biomarkers for early diagnosis and recurrence monitoring of bladder cancer","volume":"1878","author":"Zhao","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.clnu.2024.05.003_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cas.13856","article-title":"Circulating miRNA panels for specific and early detection in bladder cancer","volume":"110","author":"Usuba","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clnu.2024.05.003_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jfda.2018.11.008","article-title":"Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers","volume":"27","author":"Chen","year":"2019","journal-title":"J\u00a0Food Drug Anal"},{"key":"10.1016\/j.clnu.2024.05.003_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814374","article-title":"Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers","volume":"24","author":"Flores Monar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnu.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000478018","article-title":"Liquid biopsy: current status and future perspectives","volume":"40","author":"Mader","year":"2017","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.clnu.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41698-017-0039-5","article-title":"The potential of liquid biopsies for the early detection of cancer","volume":"1","author":"Heitzer","year":"2017","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.clnu.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mc.23349","article-title":"Pharmacologic approaches to amino acid depletion for cancer therapy","volume":"61","author":"Wilder","year":"2022","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.clnu.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.clnu.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.ircmb.2022.08.001","article-title":"Targeting amino acid metabolism in cancer","volume":"373","author":"Safrhansova","year":"2022","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.clnu.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","article-title":"Targeting amino acid metabolism for cancer therapy","volume":"22","author":"Lukey","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clnu.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.breast.2022.02.009","article-title":"Essential amino acids deprivation is a potential strategy for breast cancer treatment","volume":"62","author":"Zhao","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.clnu.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-023-02739-4","article-title":"Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts","volume":"21","author":"Rothwell","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.clnu.2024.05.003_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.pan.2019.07.002","article-title":"Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus","volume":"19","author":"Mizuno","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.clnu.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/1055-9965.EPI-18-0936","article-title":"Serum metabolic profiling identified a distinct metabolic signature in bladder cancer smokers: a key metabolic enzyme associated with patient survival","volume":"28","author":"Amara","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clnu.2024.05.003_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/cncr.31890","article-title":"Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival","volume":"125","author":"Vantaku","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/metabo12060558","article-title":"Metabolic profiling of bladder cancer patients' serum reveals their sensitivity to neoadjuvant chemotherapy","volume":"12","author":"Zhuang","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.clnu.2024.05.003_bib20","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/pmic.201200016","article-title":"LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery","volume":"12","author":"Lin","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.clnu.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2116\/analsci.28.451","article-title":"NMR-based metabolomic analysis of human bladder cancer","volume":"28","author":"Cao","year":"2012","journal-title":"Anal Sci"},{"key":"10.1016\/j.clnu.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1021\/pr400859w","article-title":"Low- and high-grade bladder cancer determination via human serum-based metabolomics approach","volume":"12","author":"Bansal","year":"2013","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.clnu.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2307\/2531743","article-title":"Power calculations for matched case-control studies","volume":"44","author":"Dupont","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.clnu.2024.05.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111868","article-title":"Fatty foods and the risk of bladder cancer: a case-control study","volume":"106","author":"Teng","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2024.05.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1051964","article-title":"Effect of dietary protein content shift on aging in elderly rats by comprehensive quantitative score and metabolomics analysis","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnu.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","article-title":"Amino acid metabolism in health and disease","volume":"8","author":"Ling","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.clnu.2024.05.003_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14789450.2019.1583105","article-title":"Recent advances in the metabolomic study of bladder cancer","volume":"16","author":"Amara","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.clnu.2024.05.003_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/metabo9010018","article-title":"GC-MS metabolomics reveals distinct profiles of low- and high-grade bladder cancer cultured cells","volume":"9","author":"Rodrigues","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.clnu.2024.05.003_bib30","first-page":"1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.clnu.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.3390\/cancers13143541","article-title":"Arginine signaling and cancer metabolism","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clnu.2024.05.003_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: a multifaceted enzyme important in health and disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clnu.2024.05.003_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40170-023-00324-0","article-title":"Metabolic changes preceding bladder cancer occurrence among Korean men: a nested case-control study from the KCPS-II cohort","volume":"11","author":"Han","year":"2023","journal-title":"Cancer Metabol"},{"key":"10.1016\/j.clnu.2024.05.003_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11255-021-03080-6","article-title":"Bladder cancer biomarker screening based on non-targeted urine metabolomics","volume":"54","author":"Li","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clnu.2024.05.003_bib35","article-title":"Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry","volume":"13","author":"J","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2024.05.003_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115473","article-title":"Targeted and untargeted urinary metabolic profiling of bladder cancer","volume":"233","author":"Ossoli\u0144ski","year":"2023","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.clnu.2024.05.003_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.chroma.2013.10.002","article-title":"Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach","volume":"1318","author":"Alberice","year":"2013","journal-title":"J\u00a0Chromatogr A"},{"key":"10.1016\/j.clnu.2024.05.003_bib38","article-title":"Evidence-based nutrition \u2014 the impact of information and selection bias on the interpretation of individual studies","volume":"16","author":"Margetts","year":"2003","journal-title":"S\u00a0Afr J Clin Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:56:40Z","timestamp":1777532200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0261561424001493"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.003","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A panel of four plasma amino acids is a promising biomarker for newly diagnosed bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}